[DOI] [PubMed] [Google Scholar] 41.Lin X., Xiao H.-M., Liu H.-M., Lv W.-Q., Greenbaum J., Gong R., et al
Your PlexusDx clinician and hepatologist should coordinate care to balance weight loss benefits with cirrhosis stability
Estudios de dexametasona en el tratamiento de CAVB han producido resultados contradictorios
doi: 10.1155/2019/5240898 115 LiK.Wohlford-LenaneC.PerlmanS.ZhaoJ.JewellA
Some patients also develop fundic gland polyps with long-term use, which are usually benign but require monitoring through endoscopic examination
An ASCO abstract reported clinically meaningful weight loss in early-stage patients using GLP-1 drugs with no immediate signal of higher recurrence risk, and an update from Memorial Sloan Kettering described similar results, noting that even a 5 percent weight loss may help counter treatment-related weight gain